NCT02082392View on ClinicalTrials.gov

Developing New Clinical Management Strategies

PHASE4CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 4, 2015

Conditions
Major Depressive Disorder
Interventions
DRUG

Escitalopram

DRUG

Placebo

A substance or treatment of no intended therapeutic value in a pill form.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT02082392 - Developing New Clinical Management Strategies | Biotech Hunter | Biotech Hunter